Clinical Trials Browser

Phase 3 × OTHER × tositumomab I-131 × Clear all

NCT00004874 2018-01-17

Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase 3 Terminated

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell